News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,290 Results
Type
Article (14976)
Company Profile (299)
Press Release (268009)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80426)
Career Advice (164)
Deals (13423)
Drug Delivery (39)
Drug Development (50759)
Employer Resources (31)
FDA (5870)
Job Trends (5194)
News (145869)
Policy (10134)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (925)
Accelerated approval (19)
Adcomms (14)
Allergies (82)
Alliances (21898)
ALS (124)
Alzheimer's disease (1031)
Antibody-drug conjugate (ADC) (241)
Approvals (6064)
Artificial intelligence (259)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4578)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (343)
Cancer (3130)
Cardiovascular disease (238)
Career advice (149)
Career pathing (8)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43716)
Collaboration (1148)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1101)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4319)
Denatured (15)
Depression (92)
Diabetes (256)
Diagnostics (1388)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (4)
Duchenne muscular dystrophy (213)
Earnings (31894)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51851)
Executive appointments (622)
FDA (7620)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (983)
Gene editing (183)
Generative AI (21)
Gene therapy (486)
GLP-1 (506)
Government (1157)
Grass and pollen (3)
Guidances (167)
Healthcare (6670)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (67)
Infectious disease (1205)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (167)
Interviews (18)
IPO (7375)
IRA (12)
Job creations (876)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1422)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (375)
MASH (130)
Medical device (2724)
Medtech (2733)
Mergers & acquisitions (6671)
Metabolic disorders (726)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1950)
Neurotech (1)
NextGen: Class of 2026 (2060)
Non-profit (873)
Now hiring (30)
Obesity (330)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (328)
Peanut (43)
People (26810)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15493)
Phase 2 (20316)
Phase 3 (12828)
Pipeline (3241)
Policy (90)
Postmarket research (854)
Preclinical (6539)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (647)
Real estate (1464)
Recruiting (12)
Regulatory (9925)
Reports (19)
Research institute (975)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (137)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2014)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (174)
Women's health (25)
Worklife (2)
Date
Last 7 days (345)
Last 30 days (1158)
Last 365 days (17819)
2026 (1655)
2025 (18121)
2024 (20589)
2023 (22502)
2022 (26930)
2021 (27939)
2020 (23503)
2019 (16325)
2018 (11818)
2017 (13798)
2016 (11887)
2015 (14384)
2014 (10426)
2013 (7531)
2012 (7608)
2011 (7711)
2010 (7507)
Location
Africa (156)
Alabama (65)
Alaska (2)
Arizona (72)
Arkansas (5)
Asia (18386)
Australia (3127)
California (7079)
Canada (1836)
China (773)
Colorado (246)
Connecticut (253)
Delaware (236)
Europe (39252)
Florida (902)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (396)
India (35)
Indiana (160)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (738)
Massachusetts (5583)
Michigan (111)
Minnesota (247)
Mississippi (3)
Missouri (43)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1645)
New Mexico (13)
New York (1761)
North Carolina (826)
North Dakota (6)
Northern California (3475)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1278)
Puerto Rico (9)
Rhode Island (25)
South America (216)
South Carolina (11)
Southern California (2808)
Tennessee (40)
Texas (906)
United States (23357)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
283,290 Results for "genesis therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe
January 7, 2026
·
4 min read
Press Releases
Zhittya Genesis Medicine Announces Initial Results Suggesting Potential Reversal of Type 2 Diabetes in Human Study
December 5, 2025
·
4 min read
Press Releases
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
February 20, 2025
·
4 min read
Press Releases
Alpha Genesis Expands GLP Capacity Following Multi-Million-Dollar Investment to Accelerate IND-Enabling Nonhuman Primate Studies
October 15, 2025
·
3 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Genesis Therapeutics Expands Leadership Team with Appointments of Chief Scientific Officer, SVP of Engineering, and Board Chairman
December 11, 2024
·
4 min read
Press Releases
Genesys Spine Launches Stasys-C™ 3DP Cervical Standalone System
May 14, 2025
·
1 min read
Biotech Bay
Genesis Therapeutics Closes Oversubscribed $200 Million Series B
Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients with severe diseases, announced today that it has closed an oversubscribed $200 million round of Series B financing.
August 21, 2023
·
5 min read
Press Releases
Genesis Therapeutics Announces New Equity Investment and Collaboration with NVIDIA to Optimize Key Computational Methods for AI-powered Drug Discovery
November 13, 2024
·
2 min read
BioMidwest
Celebrating Its Fifth Anniversary, Genesis Reference Laboratories Announces Testing Upgrades
Genesis Reference Laboratories, a leading diagnostics laboratory, is pleased to announce upgrades to its testing menus.
February 8, 2024
·
3 min read
1 of 28,329
Next
